Clinical Trial Update: A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of Oral Teslanbaicin in Patients With Radiation Proctitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial is evaluating the safety and efficacy of oral Teslanbaicin in patients with radiation proctitis; enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Proctitis

Drugs mentioned

• Teslanbaicin (teslanbaicin)

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Safety | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION